As investors ask 'What day is it?' individual stock stories shine with proactive supply chain solutions from ASOS (ASC) and platforms for growth from Microlise (SAAS), Hemogenyx (HEMO) and two SPAC IP...
Dr Vladislav Sandler, Co-Founder and CEO of HemoGenyx Pharmaceuticals #LSE #HEMO discusses two major announcements with London South East. First data results show that CDX antibodies have been succ...
#HEMO are a London-listed, US-based biotech company developing two revolutionary blood cancer treatments. CDX antibodies are intended to remove the need for chemo and radiation before a bone marrow t...